Cargando…

Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait

OBJECTIVE: Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children. DESIGN: This is a population-level retrospective cohort study. SETTING: Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhaddad, Fatemah, Abdulkareem, Ali, Alsharrah, Danah, Alkandari, Abdullah, Bin-Hasan, Saadoun, Al-Ahmad, Mona, Al Hashemi, Hashem, Alghounaim, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240452/
https://www.ncbi.nlm.nih.gov/pubmed/35768102
http://dx.doi.org/10.1136/bmjopen-2021-056371
_version_ 1784737557914845184
author Alhaddad, Fatemah
Abdulkareem, Ali
Alsharrah, Danah
Alkandari, Abdullah
Bin-Hasan, Saadoun
Al-Ahmad, Mona
Al Hashemi, Hashem
Alghounaim, Mohammad
author_facet Alhaddad, Fatemah
Abdulkareem, Ali
Alsharrah, Danah
Alkandari, Abdullah
Bin-Hasan, Saadoun
Al-Ahmad, Mona
Al Hashemi, Hashem
Alghounaim, Mohammad
author_sort Alhaddad, Fatemah
collection PubMed
description OBJECTIVE: Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children. DESIGN: This is a population-level retrospective cohort study. SETTING: Patients were identified through multiple national-level electronic COVID-19 databases that cover all primary, secondary and tertiary centres in Kuwait. PARTICIPANTS: The study included children 12 years and younger between 28 February 2020 and 6 March 2021. SARS-CoV-2 reinfection was defined as having two or more positive SARS-CoV-2 PCR tests done on a respiratory sample, at least 45 days apart. Clinical data were obtained from the Pediatric COVID-19 Registry in Kuwait. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary measure is to estimate SARS-CoV-2 PCR repositivity rate. The secondary objective was to establish average duration between first and subsequent SARS-CoV-2 infection. Descriptive statistics were used to present clinical data for each infection episode. Also, incidence-sensitivity analysis was performed to evaluate 60-day and 90-day PCR repositivity intervals. RESULTS: Thirty paediatric patients with COVID-19 had SARS-CoV-2 reinfection at an incidence of 1.02 (95% CI 0.71 to 1.45) infection per 100 000 person-days and a median time to reinfection of 83 (IQR 62–128.75) days. The incidence of reinfection decreased to 0.78 (95% CI 0.52 to 1.17) and 0.47 (95% CI 0.28 to 0.79) per person-day when the minimum interval between PCR repositivity was increased to 60 and 90 days, respectively. The mean age of reinfected subjects was 8.5 (IQR 3.7–10.3) years and the majority (70%) were girls. Most children (55.2%) had asymptomatic reinfection. Fever was the most common presentation in symptomatic patients. One immunocompromised experienced two reinfection episodes. CONCLUSION: SARS-CoV-2 reinfection is uncommon in children. Previous confirmed COVID-19 in children seems to result in a milder reinfection.
format Online
Article
Text
id pubmed-9240452
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-92404522022-06-30 Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait Alhaddad, Fatemah Abdulkareem, Ali Alsharrah, Danah Alkandari, Abdullah Bin-Hasan, Saadoun Al-Ahmad, Mona Al Hashemi, Hashem Alghounaim, Mohammad BMJ Open Infectious Diseases OBJECTIVE: Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children. DESIGN: This is a population-level retrospective cohort study. SETTING: Patients were identified through multiple national-level electronic COVID-19 databases that cover all primary, secondary and tertiary centres in Kuwait. PARTICIPANTS: The study included children 12 years and younger between 28 February 2020 and 6 March 2021. SARS-CoV-2 reinfection was defined as having two or more positive SARS-CoV-2 PCR tests done on a respiratory sample, at least 45 days apart. Clinical data were obtained from the Pediatric COVID-19 Registry in Kuwait. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary measure is to estimate SARS-CoV-2 PCR repositivity rate. The secondary objective was to establish average duration between first and subsequent SARS-CoV-2 infection. Descriptive statistics were used to present clinical data for each infection episode. Also, incidence-sensitivity analysis was performed to evaluate 60-day and 90-day PCR repositivity intervals. RESULTS: Thirty paediatric patients with COVID-19 had SARS-CoV-2 reinfection at an incidence of 1.02 (95% CI 0.71 to 1.45) infection per 100 000 person-days and a median time to reinfection of 83 (IQR 62–128.75) days. The incidence of reinfection decreased to 0.78 (95% CI 0.52 to 1.17) and 0.47 (95% CI 0.28 to 0.79) per person-day when the minimum interval between PCR repositivity was increased to 60 and 90 days, respectively. The mean age of reinfected subjects was 8.5 (IQR 3.7–10.3) years and the majority (70%) were girls. Most children (55.2%) had asymptomatic reinfection. Fever was the most common presentation in symptomatic patients. One immunocompromised experienced two reinfection episodes. CONCLUSION: SARS-CoV-2 reinfection is uncommon in children. Previous confirmed COVID-19 in children seems to result in a milder reinfection. BMJ Publishing Group 2022-06-27 /pmc/articles/PMC9240452/ /pubmed/35768102 http://dx.doi.org/10.1136/bmjopen-2021-056371 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Infectious Diseases
Alhaddad, Fatemah
Abdulkareem, Ali
Alsharrah, Danah
Alkandari, Abdullah
Bin-Hasan, Saadoun
Al-Ahmad, Mona
Al Hashemi, Hashem
Alghounaim, Mohammad
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_full Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_fullStr Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_full_unstemmed Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_short Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_sort incidence of sars-cov-2 reinfection in a paediatric cohort in kuwait
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240452/
https://www.ncbi.nlm.nih.gov/pubmed/35768102
http://dx.doi.org/10.1136/bmjopen-2021-056371
work_keys_str_mv AT alhaddadfatemah incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT abdulkareemali incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT alsharrahdanah incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT alkandariabdullah incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT binhasansaadoun incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT alahmadmona incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT alhashemihashem incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT alghounaimmohammad incidenceofsarscov2reinfectioninapaediatriccohortinkuwait